• UCLA Health
  • myUCLAhealth
  • School of Medicine
May Laboratory

May Laboratory

May Laboratory
  • Back to Division of Digestive Diseases
  • About Us
  • Health Services Research
    • Chronic Liver Disease and Hepatocellular Carcinoma
    • Colon Cancer Prevention and Control
    • Esophageal Diseases
    • Health Systems
  • Quality Improvement
  • Global Health
  • Media
    • In the News
    • Publications
  • Contact Us
  • Meet Our Team
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

May Laboratory

Health Services Research

Health Services Research

Health Services Research

  • Chronic Liver Disease and Hepatocellular Carcinoma
  • Colon Cancer Prevention and Control
  • Esophageal Diseases
  • Health Systems
  • Chronic Liver Disease and Hepatocellular Carcinoma
  • Colon Cancer Prevention and Control
  • Esophageal Diseases
  • Health Systems
  1. Home
  2. May Laboratory
  3. Health Services Research
  4. Esophageal Diseases

Esophageal Diseases

Share this
DDW

The May Laboratory

Esophageal cancer is an aggressive and deadly form of cancer. There are two major subtypes: esophageal adenocarcinoma and esophageal squamous cell carcinoma. In the United States, the epidemiology of these two subtypes is evolving, and the May Lab studies them separately as they have many distinct risk factors.

Our team uses national data and cancer registry data to study national trends in esophageal cancer incidence, mortality, survival, and disease stage at presentation in the United States.

Our team also examines national racial and ethnic disparities in esophageal cancer incidence and outcomes to better understand how all individuals, regardless of background, can have the best possible outcomes after a diagnosis of esophageal cancer.

Future studies will aim to understand how to improve the care and well-being of patients with a diagnosis of esophageal cancer at UCLA Health. We are also interested in finding ways to improve the delivery of healthcare to patients with this disease in the greater Los Angeles area.


Collaborations

  • Kevin Ghassemi, MD, Associate Clinical Professor of Medicine, David Geffen School of Medicine at UCLA
  • Jeffrey L. Conklin, MD, Professor of Clinical Medicine, David Geffen School of Medicine at UCLA
  • V. Raman Muthusamy, MD, MAS, Professor of Clinical Medicine, David Geffen School of Medicine at UCLA


Grants

  1. Corona E, Yang L, Esrailian E, May FP. Trends In Esophageal Adenocarcinoma And Squamous Cell Carcinoma Mortality And Stage At Diagnosis By Race And Ethnicity In The United States [Oral presentation at Digestive Diseases Week; 2019 May 18–21; San Diego, CA].

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth

Learn more about myUCLAhealth